✦ LIBER ✦

Sirolimus reduces the risk of significant hepatic fibrosis after liver transplantation (LTX) for hepatitis C virus (HCV): A single center experience

✍ Scribed by Mara A. Kelly; Maria Kaplan; Maxwell L. Smith; Michael Wachs; Thomas Bak; Igal Kam; Michael A. Zimmerman

Book ID: 113680675
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 54 KB
Volume: 213
Category: Article
ISSN: 1072-7515
DOI: 10.1016/j.jamcollsurg.2011.06.155

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Sirolimus Reduces the Risk of Significan

Sirolimus Reduces the Risk of Significant Hepatic Fibrosis After Liver Transplantation for Hepatitis C Virus: A Single-Center Experience

✍ Kelly, M.A.; Kaplan, M.; Nydam, T.; Wachs, M.; Bak, T.; Kam, I.; Zimmerman, M.A. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 597 KB

148 Impact of pegylated interferon alfa-

148 Impact of pegylated interferon alfa-2B and ribavirin on liver fibrosis for recurrent hepatitis C in liver transplantation-A single center experience

✍ Sandeep Mukherjee; Richard K. Gilroy; Joyce Rogge; Lynne Weaver; Timothy M. McCa 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 120 KB

A 7-gene signature of the recipient pred

A 7-gene signature of the recipient predicts the progression of fibrosis after liver transplantation for hepatitis C virus infection

✍ Nicole T. do O; Dennis Eurich; Petra Schmitz; Maximilian Schmeding; Christoph He 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 802 KB

Fibrosis recurrence after liver transplantation (LT) for hepatitis C virus (HCV) is a universal event and strongly determines a patient's prognosis. The recipient risk factors for fibrosis recurrence are still poorly defined. Here we assess a genetic risk score as a predictor of fibrosis after LT. T

Fibrosis Progression and the Pros and Co

Fibrosis Progression and the Pros and Cons of Antiviral Therapy for Hepatitis C Virus Recurrence After Liver Transplantation: A Review

✍ E. De Martin; M. Senzolo; M. Gambato; G. Germani; A. Vitale; F.R. Russo; P. Burr 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 103 KB

Factors influencing the progression of f

Factors influencing the progression of fibrosis in patients with recurrent hepatitis C after liver transplantation under antiviral therapy: A retrospective analysis of 939 liver biopsies in a single center

✍ Thomas Walter; Jérôme Dumortier; Olivier Guillaud; Valérie Hervieu; Jean-Yves Sc 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 178 KB 👁 2 views

Recurrent hepatitis C after liver transplantation (LT) is a major problem, since up to 30% of patients develop cirrhosis only 5 years after LT in the absence of antiviral therapy. The aim of this study was to examine the rate of progression of fibrosis and its associated risk factors in patients sub

Hepatitis C virus–infected women have a

Hepatitis C virus–infected women have a higher risk of advanced fibrosis and graft loss after liver transplantation than men

✍ Jennifer C. Lai; Elizabeth C. Verna; Robert S. Brown Jr.; Jacqueline G. O'Leary; 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 174 KB 👁 2 views

In natural history studies of hepatitis C virus (HCV) infection, women have a lower risk of disease progression to cirrhosis. Whether female sex influences outcomes of HCV in the posttransplantation setting is unknown. All patients transplanted for HCV-related liver disease from 2002-2007 at five Un